KRAS and colorectal carcinoma: Recently, Kwak and colleagues have illustrated in a systematic review that KRAScodon13 gene mutation appears to have worse OS in comparison to KRAS wild-type in CRC patients but shows similar clinical outcomes to codon 12 gene mutations [48].